Almost two decades of intensive research may soon lead to a major development in the search for a treatment of type 1 diabetes, one of the leading causes of death in the entire world. The recent findings from an FDA-approved clinical trial testing a
MoreSingapore eDevelopment Ltd (SeD) is pleased to announce that its U.S. biomedical subsidiary Global BioLife Inc. has developed 3F Antimicrobial
MoreAlmost two decades of intensive research may soon lead to a major development in the search for a treatment of
More